Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Ibuprofen an Option for Early Pain Control after Hip Replacement

Reuters Staff  |  February 13, 2019

NEW YORK (Reuters Health)—Combining paracetamol (acetaminophen) with ibuprofen does not cut postoperative use of morphine in a clinically meaningful way relative to ibuprofen alone, in patients undergoing total hip arthroplasty (THA), results of a Danish randomized trial suggest.

“Although the combined use of paracetamol and ibuprofen reduced immediate postoperative morphine consumption compared with paracetamol alone in patients undergoing THA, ibuprofen alone resulted in comparable pain control without increasing serious adverse events,” the researchers report in JAMA, online Feb. 12.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Kasper Højgaard Thybo from Naestved Hospital and colleagues evaluated the beneficial and harmful effects of four oral nonopioid analgesic regimens taken every six hours for 24 hours following THA and starting one hour before surgery.

By random allocation, 136 patients received 1,000 mg of paracetamol (acetaminophen) plus 400 mg of ibuprofen, 142 received 1,000 mg of paracetamol plus placebo, 141 received 400 mg of ibuprofen plus placebo and 140 received half-strength 500 mg of paracetamol plus 200 mg of ibuprofen.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The two co-primary outcomes were 24-hour morphine consumption using patient-controlled analgesia and the proportion of patients with one or more serious adverse events within 90 days.

Median 24-hour morphine consumption was 20 mg in the paracetamol/ibuprofen group, 36 mg for paracetamol alone, 26 mg for ibuprofen alone and 28 mg for half-strength paracetamol/ibuprofen.

Morphine consumption in the first 24 hours was statistically significantly lower for the combination of 1,000 mg of paracetamol plus 400 mg of ibuprofen than for either agent alone, the investigators report, findings that “support the principle of multi-modal analgesia with paracetamol plus ibuprofen compared with paracetamol alone for the first postoperative day.”

However, compared with ibuprofen alone, the morphine-sparing effect of the combination was below the prespecified threshold for a clinically important postoperative morphine reduction (10 mg), “suggesting that ibuprofen alone may be a reasonable option for early postoperative oral analgesia,” they say.

There was no statistically significant difference in the percentage of patients with serious adverse events in any of the ibuprofen groups vs. paracetamol alone (15% vs. 11%).

The authors say a limitation of the trial is that the intervention period was only 24 hours, “and a prolonged intervention period could have been more appropriate as treatment with paracetamol plus ibuprofen seldom is used for only 24 hours in a clinical context.”

The study had no commercial funding and the authors made no relevant disclosures.

Dr. Thybo did not respond to a request for comment by press time.

Page: 1 2 | Single Page
Share: 

Filed under:AnalgesicsDrug Updates Tagged with:hiphip arthroplastyIbuprofenPainPain Managementsurgerytotal hip arthroplastytotal hip replacement

Related Articles

    Hip-Resurfacing Arthroplasty an Alternative to Total Hip Replacement

    December 1, 2014

    Resurfacing procedure preserves bone, lasts longer, allows patients higher level of functionality

    How to Manage Pain in Patients with Renal Insufficiency or End-Stage Renal Disease on Dialysis

    October 1, 2013

    Narcotic and non-narcotic pain regimens can be used

    Reading Rheum

    May 1, 2007

    Handpicked Reviews of Contemporary Literature

    Collaborative Guideline Addresses the Perioperative Use of Antirheumatic Drug Therapy

    July 25, 2017

    A new guideline developed by the ACR and the American Association of Hip and Knee Surgeons addresses the perioperative use of antirheumatic drug therapy. Specifically, it provides recommendations on the use of traditional disease-modifying antirheumatic drugs, biologic agents, tofacitinib and glucocorticoids in adults with RA; SpA, including ankylosing spondylitis and psoriatic arthritis; JIA; or SLE undergoing elective THA or TKA. The guideline provides recommendations regarding when to continue, when to withhold and when to restart these medications, and the optimal perioperative dosing of glucocorticoids…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences